Allergy Therapeutics PLC has announced a notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. SkyGem Acquisition Limited, a person closely associated with Mr. Zheqing (Simon) Shen, Non-Executive Director of Allergy Therapeutics Plc, has acquired 247,935,057 ordinary shares of £0.001 each at a price of £0.01 per share. The transaction took place on November 9, 2023, at Allergy Therapeutics.